𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog

✍ Scribed by Amrita V. Kamath; Ming Chang; Francis Y. Lee; Yueping Zhang; Punit H. Marathe

Publisher
Springer
Year
2005
Tongue
English
Weight
314 KB
Volume
56
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Preclinical pharmacokinetics and metabol
Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist
✍ Nimish N. Vachharajani; Krishnaswamy Yeleswaram; David W. Boulton πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 156 KB

BMS-214778 is a novel melatonin receptor agonist that may be a useful treatment for sleep disorders that result from disruption of circadian rhythms. Pharmacokinetic studies following intravenous and oral administration and 1 month oral steady-state studies were carried out in rats and monkeys. Rat

Pharmacokinetics and bioavailability of
Pharmacokinetics and bioavailability of oral ergometrine in male volunteers
✍ A. N. J. A. De Groot; T. B. Vree; Y. A. Hekster; M. Van Den Biggelaar-Martea; P. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 2 views

The aim of this investigation was to assess the pharmacokinetics and bioavailability of ergometrine in six human male subjects after an oral dose of 0.200 mg and after an intravenous dose of 0.075 mg of ergometrine maleate. A large variation in bioavailability of between 34% and 117% in the six volu